Paolo Mallaroni
Clinical Researcher in Psychedelic Neuroscience
Data updated
Research Footprint
Paolo Mallaroni appears in 14 tracked papers (2022–2026), most studied alongside Psilocybin, Ayahuasca and 2C-X, across Neuroimaging & Brain Measures, Healthy Volunteers and Depressive Disorders.
Most-cited paper: Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study (77 citations).
Frequent co-authors: Johannes Ramaekers, Nathalie Mason and Jan Reckweg.
Background & Research
Paolo Mallaroni is a clinical researcher based at Maastricht University whose work sits at the intersection of experimental psychopharmacology, neuroimaging and cognitive neuroscience of psychedelics. He has contributed to placebo‑controlled experimental studies and multimodal imaging analyses examining acute and persisting effects of classic and novel psychoactive compounds, and has collaborated extensively with groups led by N.L. Mason and colleagues on projects spanning psilocybin, ayahuasca and 2C‑B. His research portfolio includes investigations of subjective phenomenology (including oceanic boundlessness), dynamic functional connectivity changes after psilocybin, structural cortical signatures of repeated ayahuasca use, cognitive effects on episodic familiarity, and immunological alterations following psilocybin administration.
Key Impact
Emerging clinical researcher notable for experimental studies on psilocybin, ayahuasca and 2C‑B that probe neural, immunological and cognitive effects of psychedelics in healthy volunteers.
Collaboration Network
31 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Paolo Mallaroni is associated with.